5,658 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Trexquant Investment LP

Trexquant Investment LP bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, HoldingsChannel reports. The firm bought 5,658 shares of the biopharmaceutical company’s stock, valued at approximately $523,000. Other hedge funds and other institutional investors have also bought and sold shares of the company. Southland Equity […]